Optimising value in Health Industries transactions with One Deals

Healing horizons: unleashing potential through strategic health ventures

Budgetary pressures are forcing reimbursement cuts and driving margin compression in already mature markets, limiting domestic growth opportunities. Meanwhile, increasing sophistication and scale of emerging market companies are helping to lower perceived mergers and acquisitions (M&A) risk. We engage with clients by providing fundraising support, divestiture services, evaluating buy and sell side strategy, and assisting with pre-deal clinical, financial, operational, tax due diligence, valuation, and post-deal integration and value creation. However, both local and in-bound HealthTech startups have been facing challenges in setting up and scaling up successfully in Singapore, the region and internationally, despite the nation having been deemed a thriving centre.

To achieve a vibrant and successful HealthTech industry locally, regionally and globally, an independent party to support a startup's journey from conceptualisation to–successful and sustainable–commercialisation is needed. If you are looking to play a role in the innovation space, we provide a comprehensive suite of services throughout the journey regardless of your and/or a HealthTech startup's maturity.